[Varying modification of nucleoside phosphorylation of lymphatic cells by cytostatics effective in Hodgkin's disease].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002417:Cattle; D002855:Chromatography, Thin Layer; D006689:Hodgkin Disease / Q000188:drug therapy; D006834:Hydrazines / Q000494:pharmacology; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000201:enzymology / Q000378:metabolism*; D009705:Nucleosides / Q000032:analysis / Q000378:metabolism*; D010653:Phenylbutazone / Q000494:pharmacology; D010710:Phosphates / Q000096:biosynthesis; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D011239:Prednisolone / Q000494:pharmacology; D014529:Uridine / Q000378:metabolism; D014747:Vinblastine / Q000494:pharmacology
D000970:Antineoplastic Agents; D006834:Hydrazines; D009705:Nucleosides; D010710:Phosphates; D014747:Vinblastine; D011239:Prednisolone; D010770:Phosphotransferases; D010653:Phenylbutazone; D014529:Uridine
Unterschiedliche Beeinflussung der Nucleosidphosphorylierung lymphatischer Zellen durch Morbus Hodgkin-wirksame Cytostatica.